We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 2 months
The 2023-2028 Outlook for Polycystic Ovarian Syndrome Treatments in the United States
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 1 days · 1 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 1 days • 1 price levels
Price Analysis
Most common price: £520 (1 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 1 days
Product Specifications
- Format
- paperback
- ASIN
- B0BLQK45VF
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 11 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Chronic Obstructive Pulmonary Disease Treatments in the United States
The 2023-2028 Outlook for Oligonucleotide Therapeutics in the United States
The 2023-2028 Outlook for Hormone-Drug Breast Cancer Therapeutics in the United States
The 2023-2028 Outlook for Menopausal Hot Flashes Therapies in the United States
The 2023-2028 Outlook for Women's Health Care in the United States
The 2023-2028 Outlook for Osteoarthritis Treatments in the United States
The 2023-2028 Outlook for Analgesic Osteoarthritis Treatments in the United States
The 2023-2028 Outlook for Persistent Corneal Epithelial Defects Treatments in the United States
The 2023-2028 Outlook for Pain Relief Therapies in the United States
The 2023-2028 Outlook for Stretch Marks Treatments in the United States
The 2023-2028 Outlook for Topical Pigmentation Disorders Treatment Drugs in the United States
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in the United States
The 2023-2028 Outlook for Life Science Products in the United States
The 2023-2028 Outlook for Peripheral Vascular Devices in the United States
The 2023-2028 Outlook for Canola Seed Treatments in the United States
The 2023-2028 Outlook for Chronic Obstructive Pulmonary Disease Treatments in India
The 2023-2028 Outlook for Dermatophytic Onychomycosis Treatments in the United States
The 2023-2028 Outlook for Cold Laser Therapies in the United States
The 2023-2028 Outlook for Organ Transplant Immunosuppressants in the United States
The 2023-2028 Outlook for Cosmetic Lasers in the United States
The 2023-2028 Outlook for Nutraceuticals in the United States
The 2023-2028 Outlook for Oral Anti Diabetes Drugs in the United States
The 2023-2028 Outlook for Lipids in the United States
